Eli Lilly & Co (LLY)

1,443.5 USD+1.14%close 2026-11-13Healthcare
Gurus hold8popularity #67 of 1921
Net buying (quarter)−$121.5M4 buying · 4 selling
Market Cap$1.36T52 Week Range: 851.21 – 1,443.5
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.46.85Dividend Yield: 0.43%
The live quote provider is unreachable; the last known close is shown.

Eli Lilly & Co (LLY) is not among the 30 most-held stocks of the tracked superinvestor set. Price 1443.50 USD; market cap $1.36T.

Guru Ownership

Popularity rank#67 of 1,921 securities
gurus hold it8
Net activity this quarter−$121.5M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$176.5M · 2 new buys · 2 added $298.0M · 3 reduced · 1 sold out4 net buyers · 4 net sellers
Top 5 by value
Polen Capital Management$799.9MReduced -27.1%
ARK Investment Management (Cathie Wood)$92.7MAdded +509.4%
Glenview Capital Management$69.3MNew
Sands Capital Management$54.4MAdded +37.8%
Dodge & Cox$49.5MReduced -1.8%
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2016-09-301$489.0M2.1%
2016-12-311$2.1M0.0%
2017-03-312$2.6M0.0%
2017-06-301$493.1M0.4%
2017-09-301$1.71B1.4%
2017-12-311$1.70B1.3%
2018-03-311$1.69B1.4%
2018-06-301$2.31B1.8%
2018-09-301$2.44B1.9%
2018-12-311$1.79B1.6%
2019-03-311$1.90B1.6%
2019-06-301$981.7M0.8%
2019-09-301$986.2M0.8%
2019-12-311$1.06B0.8%
2020-03-311$40.4M0.0%
2020-06-301$28.0M0.0%
2020-09-302$18.6M0.0%
2020-12-312$18.1M0.0%
2021-03-312$17.3M0.0%
2021-06-302$19.8M0.0%
2021-09-302$19.7M0.0%
2021-12-312$22.5M0.0%
2022-03-312$20.9M0.0%
2022-06-303$119.6M2.3%
2022-09-303$179.5M3.0%
2022-12-312$293.2M6.7%
2023-03-313$240.1M3.6%
2023-06-305$726.6M3.0%
2023-09-306$1.31B2.6%
2023-12-318$1.12B1.8%
2024-03-317$1.55B1.2%
2024-06-306$1.71B1.3%
2024-09-306$1.70B1.2%
2024-12-318$3.11B2.0%
2025-03-317$3.68B2.9%
2025-06-306$3.06B1.8%
2025-09-302$1.27B2.0%
2025-12-313$1.41B2.0%
2026-03-315$942.1M1.3%
2026-06-308$1.11B1.2%

Price & valuation

Prev Close1,427.23
Open—
Day Range—
52 Week Range851.21 – 1,443.5
Volume—
Avg Volume (3M)—
Market Cap$1.36TSEC 10-Q, 10/26/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.382 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.46.85SEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.30.81SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.0.43%SEC 10-K, 12/31/2025 · fiscal year

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own LLY?

Eli Lilly & Co (LLY) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on LLY bullish or bearish?

LLY is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.